Terms: = Liver cancer AND AFP, AFPD, FETA, HPAFP AND Staging
320 results:
1. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract] [Full Text] [Related]
2. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of survival and analysis of prognostic factors for patients with afp negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
5. Suppressor of Cytokine Signaling-3 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients in Egypt.
El Sharnoby A; Bedair HM; Raia GYS; Hamed N; Sabry A; Khalaf FA; Abd Elhamed MR; Abdel-Samiee M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4253-4261. PubMed ID: 38156861
[TBL] [Abstract] [Full Text] [Related]
6. An update on diagnosis and treatment of hepatoblastoma.
Cao Y; Wu S; Tang H
Biosci Trends; 2024 Jan; 17(6):445-457. PubMed ID: 38143081
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Lv TR; Hu HJ; Ma WJ; Liu F; Jin YW; Li FY
Eur J Surg Oncol; 2024 Jan; 50(1):107279. PubMed ID: 38000116
[TBL] [Abstract] [Full Text] [Related]
9. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
Espinoza AF; Patel KR; Shetty PB; Whitlock RS; Sumazin P; Yu X; Sarabia SF; Urbicain M; Heczey A; Masand P; Woodfield SE; López-Terrada DH; Vasudevan SA
Cancer Med; 2023 Dec; 12(23):21270-21278. PubMed ID: 37962078
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
11. Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients.
Bittaye SO; Kambi A; Tekanyi MAI; Tamba S; Sanneh L; Sisawo MM; Jatta A; Fatty G; Jeng A; Jallow MS; Leigh O; Njie R
BMC Gastroenterol; 2023 Sep; 23(1):321. PubMed ID: 37730538
[TBL] [Abstract] [Full Text] [Related]
12. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
Yang T; Wang N; Wang F; Liu H; Shen F; Lv G
BMJ Open; 2023 Sep; 13(9):e076467. PubMed ID: 37723113
[TBL] [Abstract] [Full Text] [Related]
13. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
[TBL] [Abstract] [Full Text] [Related]
14. A Case of Curative Treatment with Apatinib and Camrelizumab Following liver Resection for Advanced Hepatocellular Carcinoma.
Huang J; Liang R; Lu C; Lu L; Li S; Tang M; Huang X; Huang S; Mai R; Gao X; Li S; Zeng C; Lin Y; Ye J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686291
[TBL] [Abstract] [Full Text] [Related]
15. Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma.
Li Y; Wang C; Yin X; Jiang L; Li X; Yang J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14879-14888. PubMed ID: 37599316
[TBL] [Abstract] [Full Text] [Related]
16. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer.
Cao R; Jiang H; Liang G; Zhang W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12033-12045. PubMed ID: 37421456
[TBL] [Abstract] [Full Text] [Related]
17. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
Shen J; Zhou Y; Yu B; Zhao K; Ding Y
Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
[TBL] [Abstract] [Full Text] [Related]
18. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.
Mohamed IB; Ismail MS; El Sabagh A; Afifi Abdelwahab AM; Polychronopoulou E; Kuo YF; Hassan M; Goss JA; Kanwal F; Jalal PK
Cancer Med; 2023 Jul; 12(14):15011-15025. PubMed ID: 37326440
[TBL] [Abstract] [Full Text] [Related]
19. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
[TBL] [Abstract] [Full Text] [Related]
20. Overall survival among patients who undergo resection does not differ significantly between T1a and T1b hepatocellular carcinoma based on the 8
Liu YW; Li WF; Kuo FY; Eng HL; Wang CC; Lin CC; Yong CC; Yen YH
Langenbecks Arch Surg; 2023 Apr; 408(1):166. PubMed ID: 37103595
[TBL] [Abstract] [Full Text] [Related]
[Next]
